Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016-20.

Olivia H PriceNicola ManRaimondo BrunoPaul DietzeCaroline L Salom Simon LentonJodie GriggDaisy GibbsTanya WilsonLouisa DegenhardtRoanna ChanNatalie ThomasAmy Peacock

Published in: Addiction (Abingdon, England) (2021)

After COVID-19-related restrictions were introduced in Australia, use of ecstasy/MDMA, related stimulants and other licit and illicit drugs mainly appeared to remain stable or decrease, primarily due to impediments to socialization.

Keyphrases

coronavirus disease
drug induced
emergency department
adverse drug